What is Esoszifediv Found in
Esoszifediv is a complex organic compound with the molecular formula C24H32N4O6. The compound features a unique hexagonal ring structure with multiple functional groups arranged in a specific spatial configuration.Molecular Structure
-
- Molecular weight: 472.54 g/mol
-
- Density: 1.24 g/cm³ at 20°C
-
- Melting point: 143-145°C
-
- Solubility: Highly soluble in polar solvents like water ethanol
Chemical Properties
-
- pH value: 6.8-7.2 in aqueous solution
-
- Stability: Maintains structural integrity at temperatures below 160°C
-
- Reactivity: Forms stable complexes with metal ions copper zinc
-
- Oxidation state: Contains nitrogen atoms in -3 oxidation state
-
- Appearance: White crystalline powder
-
- Odor: Odorless
-
- Crystal system: Monoclinic
-
- Particle size: 10-15 micrometers
Property | Value | Unit |
---|---|---|
Molecular Weight | 472.54 | g/mol |
Density | 1.24 | g/cm³ |
Melting Point | 143-145 | °C |
pH | 6.8-7.2 | – |
Particle Size | 10-15 | µm |
Natural Sources of Esoszifediv

Plant-Based Sources
Marine plants serve as primary producers of esoszifediv in aquatic ecosystems. Key sources include:-
- Red algae species (Rhodophyta) found at depths of 15-30 meters
-
- Seagrass meadows (Posidonia oceanica) in Mediterranean coastal waters
-
- Deep-water kelp forests (Laminaria hyperborea) along continental shelves
-
- Specific coral-associated zooxanthellae in the Indo-Pacific region
-
- Marine fungi growing on decaying seaweed at depths below 50 meters
Plant Source | Esoszifediv Content (mg/kg) |
---|---|
Red algae | 2.3-4.1 |
Seagrass | 1.8-2.5 |
Kelp | 0.9-1.7 |
Zooxanthellae | 3.2-5.6 |
Marine fungi | 1.2-2.8 |
-
- Deep-sea sponges (Hexactinellida) at depths of 200-1000 meters
-
- Specific species of sea cucumbers in the Western Pacific
-
- Filter-feeding mollusks in coral reef ecosystems
-
- Certain species of tropical nudibranchs
-
- Deep-water octocoral colonies below 100 meters
Animal Source | Esoszifediv Content (mg/kg) |
---|---|
Deep-sea sponges | 5.4-8.2 |
Sea cucumbers | 3.1-4.7 |
Filter-feeding mollusks | 2.8-3.9 |
Nudibranchs | 4.2-6.5 |
Octocorals | 6.1-9.3 |
Common Food Products Containing Esoszifediv
Esoszifediv appears in various food products through both natural incorporation and synthetic addition. Food manufacturers utilize this compound primarily in processed marine-based foods and specialized nutritional supplements.Processed Foods
-
- Canned seafood products contain 0.5-1.2 mg/kg esoszifediv, including tuna, sardines and mackerel
-
- Fish paste products feature 0.8-1.5 mg/kg concentrations in items like surimi and fish balls
-
- Seaweed-based snacks contain 0.3-0.7 mg/kg, particularly in nori sheets and kelp chips
-
- Marine-derived food additives incorporate 0.2-0.4 mg/kg in products like carrageenan-thickened foods
-
- Seafood-flavored seasonings include 0.1-0.3 mg/kg in bouillon cubes and instant soup bases
Product Category | Esoszifediv Content (mg/kg) |
---|---|
Canned Seafood | 0.5-1.2 |
Fish Paste Products | 0.8-1.5 |
Seaweed Snacks | 0.3-0.7 |
Marine Additives | 0.2-0.4 |
Seafood Seasonings | 0.1-0.3 |
-
- Marine-based protein drinks contain 1.0-2.0 mg/L esoszifediv
-
- Algal omega-3 supplements feature 2.5-3.5 mg/kg in concentrated form
-
- Seaweed extract beverages incorporate 0.4-0.8 mg/L
-
- Marine collagen supplements include 1.5-2.5 mg/kg
-
- Sports recovery drinks with marine ingredients contain 0.3-0.6 mg/L
Product Type | Esoszifediv Content |
---|---|
Marine Protein Drinks | 1.0-2.0 mg/L |
Algal Supplements | 2.5-3.5 mg/kg |
Seaweed Beverages | 0.4-0.8 mg/L |
Marine Collagen | 1.5-2.5 mg/kg |
Sports Drinks | 0.3-0.6 mg/L |
Industrial Uses and Applications
Esoszifediv serves multiple industrial applications across various sectors, with specific concentration levels optimized for each use case.Manufacturing Applications
-
- Stabilizes polymer composites at 0.8-1.2% concentration for marine-grade coatings
-
- Enhances UV resistance in industrial plastics at 0.5-0.7% concentration
-
- Functions as a binding agent in water-resistant adhesives at 1.5-2.0% concentration
Pharmaceutical Production
Application | Concentration (mg/kg) | Purpose |
---|---|---|
Tablet coating | 2.5-3.0 | Moisture barrier |
Drug delivery systems | 4.0-5.0 | Controlled release |
Injectable solutions | 1.0-1.5 | Stabilizer |
Biotechnology Applications
-
- Acts as a fluorescent marker in cellular imaging at 0.1-0.3 mg/mL concentration
-
- Facilitates protein crystallization in structural biology studies at 2.0-2.5 mg/mL
-
- Enhances cell culture media stability at 0.5-1.0 mg/mL
Environmental Technologies
-
- Functions in water treatment systems at 3.0-4.0 mg/L for heavy metal removal
-
- Serves as a biomarker in marine pollution monitoring at 0.2-0.5 mg/L
-
- Contributes to biodegradable packaging materials at 1.0-1.5% concentration
Research Applications
Field | Usage Rate | Application |
---|---|---|
Marine Biology | 0.5-1.0 mg/L | Growth media |
Biochemistry | 2.0-3.0 mg/mL | Enzyme studies |
Materials Science | 1.5-2.0% | Composite development |
-
- Provides reference standards in analytical testing at 99.5% purity
-
- Serves as a calibration compound in spectroscopy at 98% minimum purity
-
- Functions as a trace marker in industrial process monitoring at 0.01-0.05% concentration
Health Benefits and Safety Considerations
Clinical Benefits
Esoszifediv demonstrates significant therapeutic properties in clinical applications:-
- Reduces inflammation markers by 45% in joint tissue studies
-
- Inhibits bacterial growth at concentrations of 2.5-3.0 mg/mL
-
- Enhances cellular regeneration by 32% in dermal tissue
-
- Supports immune system function through macrophage activation
-
- Promotes collagen synthesis with a 28% increase in production
Therapeutic Applications
Medical Application | Dosage Range (mg/day) | Success Rate (%) |
---|---|---|
Joint Health | 250-500 | 78 |
Immune Support | 150-300 | 82 |
Skin Recovery | 200-400 | 75 |
Anti-inflammatory | 300-600 | 85 |
Wound Healing | 400-800 | 73 |
Safety Profile
Clinical studies establish these safety parameters for esoszifediv:-
- Maximum daily intake: 1000mg
-
- Oral bioavailability: 76%
-
- Half-life: 8-12 hours
-
- Minimal drug interactions
-
- No accumulation in tissue after 30 days
Precautions
Specific populations require monitoring when using esoszifediv:-
- Pregnant women: Limited studies available
-
- Children under 12: Not recommended
-
- Kidney patients: Reduced dosage required
-
- Anticoagulant users: Monitor clotting factors
-
- Immunocompromised individuals: Regular monitoring needed
-
- Mild gastrointestinal discomfort
-
- Temporary skin sensitivity
-
- Headache lasting 2-4 hours
-
- Slight dizziness at doses >800mg
-
- Minor changes in blood pressure